Barriers and Facilitators to medication compliance in IBD patients


Details of Research
Contact: Jhananiee Subendran, Research Student
416-586-4800 ext 2159

Primary Investigator: Erin Kennedy, MD
Enrolment: Complete

Objective: The main aim of this study is to explore the perspectives of individuals with IBD in Toronto, Canada on barriers and facilitators to the compliance of medication.

Expectation: This research may lead to a better understanding of lower compliance rates, and suggest possible ways to improve rates.
Eligibility: Anyone over 18 years diagnosed with IBD (Crohn’s Disease, Ulcerative Colitis or Indeterminate Colitis), have been on any type of treatment for at least 2 years, and are currently on an immunomodulator (Methotrexate) or biologic (Remicade/Humira/etc).

: Participation involves a one-time interview ~30 minutes with the coordinator. Refreshments will be provided.

We would like to thank you in advance for your interest and continued support.

Please contact Jhananiee Subendran (email if you are interested in participating in this study.